Investment
Features
FeesSafety
Academy
More
Pluang+

HCTI partners with ARCB and Kanzun to launch a fund connecting Malaysian healthcare firms to U.S. markets.

Market News
17 Sep 2026
PRNewsWire
View Source
Bullish
HCTI partners with ARCB and Kanzun to launch a fund connecting Malaysian healthcare firms to U.S. markets.

Healthcare Triangle, Inc. (HCTI) has joined as the U.S. technology and capital-markets partner for the Kanzun-ARCB Growth Fund, a new initiative to help Malaysian healthcare companies expand globally. The fund combines ARCB's Middle Eastern capital network with Kanzun's local deal expertise, while HCTI prepares companies technologically and financially for U.S. market entry. This collaboration aims to create a structured pathway linking Malaysian healthcare firms to Middle Eastern investors and ultimately to U.S. capital markets, enhancing growth opportunities and international competitiveness.

Healthcare Triangle's new partnership in the Kanzun-ARCB Growth Fund is noted here with Pluang's health sector data for context. As of Sep 18, 2026 02:32 WIB, 65 of 91 priced health-sector US stocks on Pluang rose today. Notable movers include Twist Bioscience Corp at USD 158.00 with a 10.44% increase and a typical hold time of 28 days, and Novavax Inc at USD 10.08 with a 7.81% increase and 100% buy order activity.

More News

KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...

Company Fundamentals
Bearish
54 minutes ago
$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...

Market News
Bullish
2 hours ago
W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...

Analyst Insights
Bullish
2 hours ago
Micron invests $10B in new research labs, backed by strong financial health and strategic leadership.

Micron invests $10B in new research labs, backed by strong financial health and strategic leadership.

Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...

Market News
Bullish
2 hours ago
Impact Biomedical executes 1-for-12.62 reverse stock split ahead of Zoar Ltd. merger

Impact Biomedical executes 1-for-12.62 reverse stock split ahead of Zoar Ltd. merger

Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App